Jagson Pal Pharmaceuticals Limited. - Company Profile

It is a pharma public limited company based in New Delhi, Delhi, India, established in 1978.

1978 New Delhi, Delhi, India Active

Last Updated: January 04, 2026

About Jagson Pal Pharmaceuticals Limited.

Jagson Pal Pharmaceuticals Limited., a active public limited company, was established on 17 August 1978 in New Delhi, Delhi, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L74899DL1978PLC009181. Registered under ROC Roc Delhi. it is listed on BSE: 507789 and NSE: JAGSNPHARM. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹13.36 Cr.

Formerly known as Jagson Pal Pharmaceuticals Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹217.98 Cr and a net worth of ₹187.40 Cr. Employing 1,308 professional, Its leadership includes Pallavi Dinodia Gupta (Director), Radhika Carlton Pereira (Director), Debasis Bikash Nandy (Director). Past directors included Ishpal Singh Ghai, Bharat Sinh, Surinder Kumar Goyal. It holds no open charges and ₹80.80 Cr settled loans. Its latest AGM occurred on 24 September 2025, with the balance sheet filed on 31 March 2025. It is based at Innov8 3Rd Floor, Plot No. 211, Okhla Phase-3, New Delhi, New Delhi, Delhi, 110020.

Company Details

CIN/LLPIN
L74899DL1978PLC009181
Registration Number
009181
Incorporation Date
17 August 1978
Authorized Capital
₹25.00 Cr
Paid-Up Capital
₹13.36 Cr
ROC Code
Roc Delhi
Listing Status
Listed (BSE: 507789, NSE: JAGSNPHARM)
Company Status
Active

Key Metrics

Authorised Capital ₹ 25.00 Cr as on 04-01-2026
Paid Up Capital ₹ 13.36 Cr as on 04-01-2026
Company Age 47 Year, 6 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 80.80 Cr as on 04-01-2026
Revenue Growth **** -10.09% (FY 2024)
Profit Growth **** -15.94% (FY 2024)
Ebitda **** -32.46% (FY 2024)
Net Worth 17.94% (FY 2024)
Total Assets **** 11.35% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Jagson Pal Pharmaceuticals Limited. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Jagson Pal Pharmaceuticals Limited.?

Current Directors

Name	Designation	Appointment Date	Status
Pallavi Dinodia Gupta	Director	29 Jun 2022	Current
Radhika Carlton Pereira	Director	29 Jun 2022	Current
Debasis Bikash Nandy	Director	29 Jun 2022	Current
Prithipal Singh Kochhar	Nominee Director	29 Jun 2022	Current
Harsha Raghavan	Nominee Director	29 Jun 2022	Current
Manish Gupta	Managing Director	16 Jul 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	29 Sep 2017	Past
Pramod Abcsdd	Additional Director	29 Sep 2017	Past
Pramod Abcsdd	Director	14 Feb 2017	Past
Pramod Abcsdd	Director	31 Mar 2013	Past
Pramod Abcsdd	Cfo	22 Jan 2025	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Jagson Pal Pharmaceuticals.

Jagson Pal Pharmaceuticals Limited., for the financial year ended 2024, experienced significant reduction in revenue, with a 10.09% decrease. The company also saw a substantial fall in profitability, with a 15.94% decrease in profit. The company's net worth Soared by an impressive increase of 17.94%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-10.09%

*******

Revenue from Operations

*******

-11.83%

*******

Total Assets

*******

11.35%

*******

Profit or Loss

*******

-15.94%

*******

Net Worth

*******

17.94%

*******

EBITDA

*******

-32.46%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Jagson Pal Pharmaceuticals?

In 2024, Jagson Pal Pharmaceuticals had a promoter holding of 68.35% and a public holding of 31.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹808,000,000.00

Charges Breakdown by Lending Institutions

Punjab & Sind Bank : 60.90 Cr
Others : 19.90 Cr

Latest Charge Details

Date	Lender	Amount	Status
26 Oct 2010	Punjab & Sind Bank	₹6.70 Cr	Satisfied
26 Oct 2010	Punjab & Sind Bank	₹3.00 M	Satisfied
26 Oct 2010	Punjab & Sind Bank	₹31.90 Cr	Satisfied
28 Jun 2006	Punjab & Sind Bank	₹22.00 Cr	Satisfied
28 Jun 2006	Others	₹19.90 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Jagson Pal Pharmaceuticals?

Jagson Pal Pharmaceuticals has a workforce of 1308 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Jagson Pal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagson Pal Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Jagson Pal Pharmaceuticals

Recent Activity within the Organization

Director Appointment

Progress on Nirav Niranjankumar Vora was appointed as a Cfo was appointed as a Cfo on 04 Nov 2025 & has been associated with this company since 3 months 12 days . was documented.
04 Nov 2025
Annual General Meeting

Jagson Pal Pharmaceuticals Limited. last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records. was recorded as a recent event.
24 Sep 2025
Balance Sheet

Progress on Jagson Pal Pharmaceuticals Limited. has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
31 Mar 2025
Director Appointment

Progress on Abhishek Joshi was appointed as a Company Secretary was appointed as a Company Secretary on 04 Apr 2023 & has been associated with this company since 2 years 10 months . was documented.
04 Apr 2023
Director Appointment

Manish Gupta was appointed as a Managing Director was appointed as a Managing Director on 16 Jul 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
16 Jul 2022
Director Appointment

Progress on Pallavi Dinodia Gupta was appointed as a Director was appointed as a Director on 29 Jun 2022 & has been associated with this company since 3 years 7 months . was documented.
29 Jun 2022

Explore recent activity and updates - View Recent Activity